ESR2 and breast cancer: In cases with ERβ (−) expression, Lumina A type breast cancer had the highest proportion (34.2%, 97/284) while Her-2 over-expression type (17.3%, 49/284) and basal like type (22.2%, 63/284) had the lowest proportion.